Pocket Guide To Mycological Diagnosis, 1st Edition Complete PDF Download
Pocket Guide To Mycological Diagnosis, 1st Edition Complete PDF Download
Visit the link below to download the full version of this book:
https://medipdf.com/product/pocket-guide-to-mycological-diagnosis-1st-edition/
Edited by
Rossana de Aguiar Cordeiro
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742
This book contains information obtained from authentic and highly regarded sources.
Reasonable efforts have been made to publish reliable data and information, but the
author and publisher cannot assume responsibility for the validity of all materials or
the consequences of their use. The authors and publishers have attempted to trace
the copyright holders of all material reproduced in this publication and apologize to
copyright holders if permission to publish in this form has not been obtained. If any
copyright material has not been acknowledged, please write and let us know so we
may rectify in any future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted,
reproduced, transmitted, or utilized in any form by any electronic, mechanical, or
other means, now known or hereafter invented, including photocopying, microfilm-
ing, and recording, or in any information storage or retrieval system, without written
permission from the publishers.
For permission to photocopy or use material electronically from this work, please
access www.copyright.com (http://www.copyright.com/) or contact the Copyright
Clearance Center, Inc. (CCC), 222 Rosewood Drive, Danvers, MA 01923, 978-750-
8400. CCC is a not-for-profit organization that provides licenses and registration for a
variety of users. For organizations that have been granted a photocopy license by the
CCC, a separate system of payment has been arranged.
Preface vii
Editor ix
Contributors xi
List of Abbreviations xiii
3 Candida spp. 29
Silviane Praciano Bandeira, Glaucia Morgana de Melo Guedes, and
Débora de Souza Colares Maia Castelo-Branco
4 Cryptococcus 39
Luciana Trilles, Márcia dos Santos Lazéra, and Bodo Wanke
5 Trichosporon 47
João Nobrega de Almeida Júnior
6 Malassezia 53
Reginaldo Gonçalves de Lima-Neto, Danielle Patrícia Cerqueira
Macêdo, Ana Maria Rabelo de Carvalho, Carolina Maria da Silva, and
Rejane Pereira Neves
7 Rhodotorula spp. 63
Rejane Pereira Neves, Ana Maria Rabelo de Carvalho, Carolina
Maria da Silva, Danielle Patrícia Cerqueira Macêdo, and Reginaldo
Gonçalves de Lima-Neto
8 Dermatophytes 69
Germana Costa Paixão, Marcos Fábio Gadelha Rocha, Débora de
Souza Colares Maia Castelo-Branco, Raimunda Sâmia Nogueira
Brilhante, and José Júlio Costa Sidrim
9 Aspergillus spp. 83
Reginaldo Gonçalves de Lima-Neto, Patrice Le Pape, and Rejane
Pereira Neves
v
vi Contents
10 Mucorales 91
Rejane Pereira Neves, André Luiz Cabral Monteiro de Azevedo
Santiago, and Reginaldo Gonçalves de Lima-Neto
11 Sporothrix spp. 99
Anderson Messias Rodrigues, Rosane Orofino-Costa, and Zoilo Pires
de Camargo
14 Coccidioides 135
Rossana de Aguiar Cordeiro
Index 153
Preface
In the past three decades, the epidemiology of fungal infections has changed dramatically.
Along with the AIDS pandemic, extensive medical progress has led to an increase in the
global population of severely immunocompromised patients, who are vulnerable to fungal
pathogens. Since proper diagnosis is considered a pivotal factor for patient management,
routine microbiology laboratories have been overloaded with requests for mycological tests.
This situation has compelled many microbiologists to seek ongoing education in medical
mycology—a field of knowledge neglected in many health courses.
In addition, the science of medical mycology has witnessed tremendous changes since the
1980s. The description of new species and species complexes, the discovery of fungal biofilms
and their importance in pathogenesis, the continuous reports of refractory infections and
antifungal resistance, and the increasing list of opportunistic fungal species have highlighted
the importance of mycological diagnosis.
Cellular and molecular techniques, immunological methods, and more accurate microscopy
equipment are now available to mycology laboratories. Furthermore, information regarding
medical mycology, including identification of specific fungal pathogens, is widely available on
the World Wide Web. Mycologists have to face the challenge of systematizing all this body of
knowledge and applying it in routine diagnosis.
Therefore, this book aims to provide concise and useful information for microbiologists
and professionals interested in the diagnosis of the most relevant fungal species of medical
importance. Potential contributors were chosen based on their personal experience and previous
authorship of widely cited publications on the subject.
We hope this book inspires young mycologists worldwide and contributes to enhancing the
detection of fungal pathogens in routine laboratories.
vii
Editor
ix
Contributors
xi
xii Contributors
AD atopic dermatitis
AdoMet/SAM S-adenosylmethionine
AFLP amplified fragment length polymorphism
ARF ADP-ribosylation factor
ART antiretroviral therapy
ASR analyte-specific reagent
AST Antimicrobial susceptibility testing
BAL Bronchoalveolar lavage
BDG 1–3-β-D-glucan
BHI brain heart infusion agar
BSL biosafety level
CDC Centers for Disease Control and Prevention
CF complement fixation
CFW calcofluor white fluorescent stain
CGB l-canavanine glycine bromothymol blue
CLSI Clinical Laboratory Standards Institute
CNS central nervous system
CrAg cryptococcal capsular polysaccharide antigen
CSF cerebrospinal fluid
CVC central venous catheters
DGGE denaturing gradient gel electrophoresis
ECV or ECOFF epidemiological cut-off value
EDTA ethylenediamine tetraacetic acid
EIA enzyme immunoassay
ELISA enzyme-linked immunosorbent assay
EUCAST European Committee on Antimicrobial Susceptibility Testing
FFPE formalin-fixed paraffin-embedded tissue
FISH fluorescence in situ hybridization
FITC fluorescein isothiocyanate
FL folliculitis
FTD fast track diagnostics
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GMS Gomori methenamine-silver nitrate stain
gp43 glycoprotein of 43,000 daltons (Paracoccidioides antigen)
GXM capsular antigen glucuronoxylomannan from Cryptococcus
HE hematoxylin and eosin
HIV human immunodeficiency virus
HPA H. capsulatum polysaccharide antigen
ID immunodiffusion
IF immunofluorescence
IGS intergenic spacer-1
IRIS immune reconstitution inflammatory syndrome
ISHAM International Society of Human and Animal Mycology
ITS internal transcribed spacer
KL-6 Krebs von den Lungen-6 antigen
KOH potassium hydroxide
LA latex agglutination test
LAMP loop-mediated isothermal amplification
LDH lactate dehydrogenase
LFA lateral flow immunoassay
LSU large subunit
MALDI-TOF MS matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
MEC minimum effective concentration
MGG May-Grünwald Giemsa
MIC minimum inhibitory concentration
ML maximum likelihood
MLST multilocus sequence typing
xiii
xiv List of Abbreviations
Contents
1.1 Introduction 1
1.2 Collection of clinical specimens 1
1.3 Mycological processing (conventional tests) 5
1.3.1 Direct microscopic examination 5
1.3.2 Culture 5
1.4 Identification 5
1.4.1 Standard culture-based methods: Phenotypical analysis 5
1.4.2 Culture-independent methods 11
1.4.2.1 Molecular diagnosis 11
1.4.2.2 Immunological diagnosis 15
1.4.2.3 Matrix-assisted laser desorption ionization-time of flight
mass spectrometry 15
1.5 Conclusions 18
Bibliography 18
1.1 Introduction
Mycological laboratories have an important role in the complex scenario of understanding the
etiology of fungal infections. They provide information not only related to diagnosis, but also to
the treatment, prevention, and control of mycosis. Through such technical data, it is also possible
to gain insight into the epidemiology of fungal infections, which brings great responsibilities to
the lab staff. Therefore, standardized and internationally validated protocols and routines must
be followed.
In order to achieve these goals, mycological labs need to be equipped with biosafety items:
individual and community barriers must be available (Table 1.1), and personnel must be
engaged in continuous biosafety training. Labs pertaining only to dermatological routines
need to be designed to reach level 2 biological safety criteria. On the other hand, labs with
complex attendance routines, that is, oncological patients, post-transplant patients, and
patients suspected of deep-seated infections, need risk 3 biological safety criteria. Additionally,
mycologists need continued education to become familiar with new fungal species and modern
diagnostic procedures. A general scheme of mycological diagnosis stages is shown in Figure 1.1.
After clinical examination of the patient by physicians, the first step of mycological diagnosis is
to collect clinical specimens. Mycologists should be aware that: (a) specimens must always be
collected from the representative site of infection, (b) collection should preferably be performed
prior to the start of antifungal therapy, (c) the amount of material collected should be suitable
for performing all the required tests, (d) specimens should be transported to the lab and
processed as soon as possible, and (e) all clinical material can be infected with other hazardous